Portland Diabetes & Endcrnlgy Portland, OR - 97225

Portland Diabetes & Endcrnlgy is categorized under Doctors in Portland, OR and active since 1987.

Portland Diabetes & Endcrnlgy was established in 1987, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Debra Bartel, Office Manager at the company’s single location by writing to 9135 Sw Barnes Road # 985, Portland, Oregon OR 97225 or by phoning (503) 297-3336. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Portland Diabetes & Endcrnlgy
Contact Person: Debra Bartel, Office Manager
Address: 9135 Sw Barnes Road # 985, Portland, Oregon 97225
Phone Number: (503) 297-3336
Website Address: pdc.org
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1987
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Portland Diabetes & Endcrnlgy was started in 1987 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Debra Bartel, Office Manager for inquiries that concern Portland Diabetes & Endcrnlgy by calling the company number (503) 297-3336, as your correspondence is most welcome. Additionally, the physical location of the single location of Portland Diabetes & Endcrnlgy can be found at the coordinates 45.50883,-122.77034 as well as the street address 9135 Sw Barnes Road # 985 in Portland, Oregon 97225.

For its online presence, you may visit Portland Diabetes & Endcrnlgy’s website at pdc.org and engage with its social media outlets through on Twitter and on Facebook.